Myung Ju Ahn - Samsung Medical Center, Seoul, South Korea

基本信息

浏览量：201

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 181 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Phase I/II Study of Davutamig (REGN5093), a METxMET Bispecific Antibody, in Patients with MET-altered, Advanced Non-Small Cell Lung Cancer (ansclc): Trial in Progress Update

M-j. Ahn,B. C. Cho,T. M. Kim,J-y. Han, C. Kim,B. Shim, A. Drilon,G. Blumenschein,L. Villaruz,J. E. Gray,J-l. Pujol,H. Lena,D. Moro-Sibilot, J. Perez, D. A. Modi, J. S. Park, S. Patel, S. Li, E. Kim,H. Magnan

ANNALS OF ONCOLOGY (2024): S1673-S1674

引用0浏览0引用

1270P Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Single-Arm, Phase II Multi-Center Trial

S. Park,H.K. Ahn, S. Lee,Y.J. Min,H.A. Jung, J-M. Sun, S-H. Lee, J.S. Ahn,M-J. Ahn, J.B. Lee,S.M. Lim,H.R. Kim,B.C. Cho,M.H. Hong

Annals of Oncology（2024）

引用0浏览0引用

1216P Adjuvant Pembrolizumab Therapy for Completely Resected Stage I NSCLC with Micropapillary or Solid Histological Subtype

S-H. Lee, Y. Bang, S. Park,H-A. Jung,J-M. Sun, J.S. Ahn,M-J. Ahn, Y. Jeon, J. Lee, J.H. Cho, H.K. Kim, Y.S. Choi, Y.M. Shim,Y-L. Choi, J. Han, J. Kim

Annals of Oncology (2024): S783

引用0浏览0引用

Updated Safety Analysis of Encorafenib Plus Binimetinib in Patients with BRAF V600e-Mutant Metastatic NSCLC from PHAROS Study

E. Smit,M-J Ahn, I. Dagogo-Jack,E. Felip,F. Gelsomino, B. Johnson, M. Johnson,M. V. Negrao,M. Offin,S. Ramalingam,R. Sanborn,A. Tsao,K. Wilner, A. Alcasid,T. Usari, X. Zhang,G. Riely

JOURNAL OF THORACIC ONCOLOGYno. 10 (2024): S77-S78

引用0浏览0引用

Tarlatamab Plus Durvalumab As First-Line Maintenance in Extensive-Stage Small Cell Lung Cancer: DeLLphi-305 Phase 3 Trial

M. Perol,M. -J. Ahn,Y. Cheng, J. Clarke,A. -M. Dingemans,C. Gay,A. Navarro,M. Schuler, T. Yoshida,P. Martinez, E. S. Anderson,J. Sands

JOURNAL OF THORACIC ONCOLOGYno. 10 (2024): S206-S207

引用0浏览0引用

Ifinatamab Deruxtecan (I-Dxd) in Extensive-Stage Small Cell Lung Cancer (ES-SCLC): Interim Analysis of Ideate-lung01

C. M. Rudin,M. -J. Ahn, M. Johnson,C. L. Hann,N. Girard,M. Nishio, Y. Cheng, H. Hayashi, Y. Jung Kim,A. Navarro, Y. Chen, T. Sakai,M. Qian, J. Godard, M. Tang, J. Singh,L. Paz-Ares

JOURNAL OF THORACIC ONCOLOGYno. 10 (2024): S15-S16

引用0浏览0引用

Datopotamab Deruxtecan Vs Docetaxel in Patients with Non-Small Cell Lung Cancer: Final Overall Survival from TROPION-Lung01

JOURNAL OF THORACIC ONCOLOGYno. 10 (2024): S24-S24

引用0浏览0引用

721Tip A Phase I/II Study of Davutamig (REGN5093), a MET×MET Bispecific Antibody, in Patients with MET-altered, Advanced Non-Small Cell Lung Cancer (ansclc): Trial in Progress Update

M-J. Ahn,B.C. Cho,T.M. Kim,J-Y. Han, C. Kim,B. Shim, A. Drilon,G. Blumenschein,L. Villaruz,J.E. Gray,J-L. Pujol,H. Lena,D. Moro-Sibilot,J. Perez, D.A. Modi, J.S. Park,S. Patel, S. Li, E. Kim,H. Magnan

Annals of Oncology (2024): S1673-S1674

引用0浏览0引用

152P Treatment (tx) Patterns and Clinical Outcomes in Unresectable Stage III Epidermal Growth Factor Receptor-Mutation Positive (egfrm) Non-Small Cell Lung Cancer (NSCLC) Treated with Chemoradiotherapy (CRT): Interim Analysis of a Global Real-World (RW) Study

J. Neal, J.B. Lee,M-J. Ahn, R. Ariyasu, C. Nash, D. Smith,S. Nagar,M. Jimenez,D.A. Kahangire, Y.J. Kim, F. Nasirova,S.H. Lin

ESMO Open (2024): 102907

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn